H. Pylori Infection and Metabolic Syndrome: A Retrospective Cross-Sectional Study
Key facts
- Who runs it
- Nanjing First Hospital, Nanjing Medical University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 5,218 people enrolled
- Started
- 1 May 2024
- Ended
- 1 Mar 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- No intervention. This is an observational study.
- Record updated
- 16 June 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age ≥18 years
- Completed annual health examination at Nanjing First Hospital Health Management Center between May 1, 2024 and May 1, 2025
- Underwent 13C or 14C urea breath test for H. pylori status assessment
- Complete data on the following measurements: height, weight, waist circumference, systolic blood pressure, diastolic blood pressure, fasting blood glucose, triglycerides, and high-density lipoprotein cholesterol
- No missing data on key study variables
Who cannot take part
- History of severe liver dysfunction
- History of severe kidney dysfunction
- History of malignancy
- Missing any of the following primary metabolic indicators: waist circumference, blood pressure (systolic/diastolic), fasting blood glucose, triglycerides, or HDL-cholesterol
- Missing key data on H. pylori test results (13C or 14C urea breath test)
- Pregnancy or lactation
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This retrospective cross-sectional study evaluates the association between Helicobacter pylori infection and metabolic syndrome using health examination data from 5,218 adults at Nanjing First Hospital. Participants are divided into H. pylori-positive and negative groups based on urea breath test results. The primary outcome is metabolic syndrome prevalence (CDS 2020 criteria). Multivariable logistic regression will be used to assess the independent association, with subgroup analyses by age and sex.
The 2 groups in the trial
- H. pylori Positive Group
Participants with positive 13C or 14C urea breath test result
Treatment: No intervention. This is an observational study.
- H. pylori Negative Group
Participants with negative 13C or 14C urea breath test result
Treatment: No intervention. This is an observational study.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Association Between Helicobacter Pylori Infection and Metabolic Syndrome: A Retrospective Cross-Sectional Study
- Record updated
- 16 June 2026